<i>WISP</i> genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors

Diane Pennica(University of Leeds), Todd A. Swanson(University of Leeds), James W. Welsh(University of Leeds), Margaret Roy(University of Leeds), David A. Lawrence(University of Leeds), James Lee(University of Leeds), Jennifer Brush(University of Leeds), Lisa A. Taneyhill(University of Leeds), Bethanne Deuel(University of Leeds), Michael A. Lew(University of Leeds), Colin Watanabe(University of Leeds), Robert L. Cohen(University of Leeds), Mona F. Melhem(University of Leeds), Gene Grant Finley(University of Leeds), Philip Quirke(University of Leeds), Audrey D. Goddard(University of Leeds), Kenneth J. Hillan(University of Leeds), Austin Gurney(University of Leeds), David Botstein(University of Leeds), Arnold J. Levine(University of Leeds)
Proceedings of the National Academy of Sciences
December 8, 1998
Cited by 513Open Access
Full Text

Abstract

Wnt family members are critical to many developmental processes, and components of the Wnt signaling pathway have been linked to tumorigenesis in familial and sporadic colon carcinomas. Here we report the identification of two genes, WISP-1 and WISP-2, that are up-regulated in the mouse mammary epithelial cell line C57MG transformed by Wnt-1, but not by Wnt-4. Together with a third related gene, WISP-3, these proteins define a subfamily of the connective tissue growth factor family. Two distinct systems demonstrated WISP induction to be associated with the expression of Wnt-1. These included (i) C57MG cells infected with a Wnt-1 retroviral vector or expressing Wnt-1 under the control of a tetracyline repressible promoter, and (ii) Wnt-1 transgenic mice. The WISP-1 gene was localized to human chromosome 8q24.1-8q24.3. WISP-1 genomic DNA was amplified in colon cancer cell lines and in human colon tumors and its RNA overexpressed (2- to >30-fold) in 84% of the tumors examined compared with patient-matched normal mucosa. WISP-3 mapped to chromosome 6q22-6q23 and also was overexpressed (4- to >40-fold) in 63% of the colon tumors analyzed. In contrast, WISP-2 mapped to human chromosome 20q12-20q13 and its DNA was amplified, but RNA expression was reduced (2- to >30-fold) in 79% of the tumors. These results suggest that the WISP genes may be downstream of Wnt-1 signaling and that aberrant levels of WISP expression in colon cancer may play a role in colon tumorigenesis.


Related Papers